Cizzle Biotechnology (LON:CIZ) Trading Up 1.4% – Should You Buy?

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s share price shot up 1.4% during mid-day trading on Wednesday . The stock traded as high as GBX 2.60 and last traded at GBX 2.54. Approximately 193,484 shares traded hands during trading, a decline of 87% from the average session volume of 1,519,876 shares. The stock had previously closed at GBX 2.50.

Cizzle Biotechnology Stock Performance

The firm has a market cap of £10.77 million, a PE ratio of -14.91 and a beta of 0.02. The stock’s 50 day simple moving average is GBX 2.87 and its 200 day simple moving average is GBX 2.13.

Cizzle Biotechnology (LON:CIZ) last issued its quarterly earnings results on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.